Hospital-acquired pneumonia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Replaced content with "__NOTOC__ {{Hospital-acquired pneumonia}} {{CMG}} ==Overview== ==Epidemiology and Demographics== ==References== {{reflist|2}} Category:Disease Category:Pulmonolo...")
m (Changes made per Mahshid's request)
 
(9 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hospital-acquired pneumonia}}
{{Hospital-acquired pneumonia}}
{{CMG}}
{{CMG}}; {{AE}} {{AL}}
==Overview==
==Overview==
The epidemiology of health-care-associated pneumonia varies considerably according to the type of health-care setting. Nosocomial pneumonia has been the second most common hospital-associated infection after that of the urinary tract. The primary risk factor for the development of hospital-associated bacterial pneumonia is mechanical ventilation.  In long-term care facilities such as nursing homes, pneumonia is the first or second most common infection (after those of the urinary tract) acquired by patients, and accounts for 13-48% of all nursing home-associated infections. <ref> {{cite web|url=http://www.cdc.gov/hicpac/pdf/guidelines/HApneu2003guidelines.pdf |title=CDC GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003}}</ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==
*Pneumonia has accounted for approximately 20% of all hospital-associated infections and 27% and 24% of all infections acquired in the medical intensive-care unit (ICU) and coronary care unit, respectively. <ref name="MagillEdwards2014">{{cite journal|last1=Magill|first1=Shelley S.|last2=Edwards|first2=Jonathan R.|last3=Bamberg|first3=Wendy|last4=Beldavs|first4=Zintars G.|last5=Dumyati|first5=Ghinwa|last6=Kainer|first6=Marion A.|last7=Lynfield|first7=Ruth|last8=Maloney|first8=Meghan|last9=McAllister-Hollod|first9=Laura|last10=Nadle|first10=Joelle|last11=Ray|first11=Susan M.|last12=Thompson|first12=Deborah L.|last13=Wilson|first13=Lucy E.|last14=Fridkin|first14=Scott K.|title=Multistate Point-Prevalence Survey of Health Care–Associated Infections|journal=New England Journal of Medicine|volume=370|issue=13|year=2014|pages=1198–1208|issn=0028-4793|doi=10.1056/NEJMoa1306801}}</ref>
===Incidence===
*The incidence of HAP is 5-15 cases per 1 000 hospital admissions. <ref>{{cite journal|title=Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia|journal=American Journal of Respiratory and Critical Care Medicine|volume=171|issue=4|year=2005|pages=388–416|issn=1073-449X|doi=10.1164/rccm.200405-644ST}}</ref>
*The incidence of VAP is 6 to 20 times more than in patients without mechanical support.
{| style="border: 0px; font-size: 85%; margin: 3px; width:380px; float:right" align=center
|valign=top|
|+
! style="background: #4479BA; color:#FFF;  width: 200px;" | Age
! style="background: #4479BA; color:#FFF;  width: 200px;" | Females
! style="background: #4479BA; color:#FFF;  width: 200px;" | Males
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | 18-44 years
| style="padding: 5px 5px; background: #F5F5F5;" | 5%
| style="padding: 5px 5px; background: #F5F5F5;" | 4%
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | 45-64 years
| style="padding: 5px 5px; background: #F5F5F5;" | 14%
| style="padding: 5px 5px; background: #F5F5F5;" | 13%
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | ≥ 65 years
| style="padding: 5px 5px; background: #F5F5F5;" | 34%
| style="padding: 5px 5px; background: #F5F5F5;" | 30%
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | Total
| style="padding: 5px 5px; background: #F5F5F5;" | 53%
| style="padding: 5px 5px; background: #F5F5F5;" | 47%
|-
| style="padding: 5px 5px; background: #F5F5F5;" colspan=3 | <small>Table adapted from 2009–2011 National Medicare Patient Safety Monitoring System <ref name="EckenrodeBakullari2014">{{cite journal|last1=Eckenrode|first1=Sheila|last2=Bakullari|first2=Anila|last3=Metersky|first3=Mark L.|last4=Wang|first4=Yun|last5=Pandolfi|first5=Michelle M.|last6=Galusha|first6=Deron|last7=Jaser|first7=Lisa|last8=Eldridge|first8=Noel|title=The Association between Age, Sex, and Hospital-Acquired Infection Rates: Results from the 2009–2011 National Medicare Patient Safety Monitoring System|journal=Infection Control and Hospital Epidemiology|volume=35|issue=S3|year=2014|pages=S3–S9|issn=0899823X|doi=10.1086/677831}}</ref></small>
|}
===Mortality===
*HAP and VAP are nosocomial infections with a high mortality in contrast with other nosocomial infections.
*This higher mortality rate is associated with MDR pathogens.
===Age===
*HAP is more commonly reported in patients > 65 years, probably due to the fact that this age population is more commonly hospitalized.
===Gender===
*There is no predominance in gender, although some data reports a higher incidence among females.
=== Ventilator-associated Pneumonia ===
*VAP occurs in up to 25% of all people who require mechanical ventilation.
*VAP can develop at any time during ventilation, but occurs more often in the first few days after intubation.
*This is because the intubation process itself contributes to the development of VAP.
*VAP occurring early after intubation typically involves fewer resistant organisms and is thus associated with a more favorable outcome.
*Because respiratory failure requiring mechanical ventilation is itself associated with a high mortality, determination of the exact contribution of VAP to mortality has been difficult.
*As of [[2006]], estimates range from 33% to 50% death in patients who develop VAP.
*Mortality is more likely when VAP is associated with certain microorganisms (''Pseudomonas'', ''Acinetobacter''), [[Bacteremia|blood stream infections]], and ineffective initial antibiotics.
*VAP is especially common in people who have [[acute respiratory distress syndrome]] (ARDS).




Line 12: Line 65:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Infectious disease]]
 
[[Category:Pneumonia]]
[[Category:Pneumonia]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]

Latest revision as of 18:02, 18 September 2017

Pneumonia Main Page

Hospital-acquired pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hospital-Acquired Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Algorithm

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hospital-acquired pneumonia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hospital-acquired pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hospital-acquired pneumonia epidemiology and demographics

CDC onHospital-acquired pneumonia epidemiology and demographics

Hospital-acquired pneumonia epidemiology and demographics in the news

Blogs on Hospital-acquired pneumonia epidemiology and demographics

Directions to Hospitals Treating Hospital-acquired pneumonia

Risk calculators and risk factors for Hospital-acquired pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

The epidemiology of health-care-associated pneumonia varies considerably according to the type of health-care setting. Nosocomial pneumonia has been the second most common hospital-associated infection after that of the urinary tract. The primary risk factor for the development of hospital-associated bacterial pneumonia is mechanical ventilation. In long-term care facilities such as nursing homes, pneumonia is the first or second most common infection (after those of the urinary tract) acquired by patients, and accounts for 13-48% of all nursing home-associated infections. [1]

Epidemiology and Demographics

  • Pneumonia has accounted for approximately 20% of all hospital-associated infections and 27% and 24% of all infections acquired in the medical intensive-care unit (ICU) and coronary care unit, respectively. [2]

Incidence

  • The incidence of HAP is 5-15 cases per 1 000 hospital admissions. [3]
  • The incidence of VAP is 6 to 20 times more than in patients without mechanical support.
Age Females Males
18-44 years 5% 4%
45-64 years 14% 13%
≥ 65 years 34% 30%
Total 53% 47%
Table adapted from 2009–2011 National Medicare Patient Safety Monitoring System [4]

Mortality

  • HAP and VAP are nosocomial infections with a high mortality in contrast with other nosocomial infections.
  • This higher mortality rate is associated with MDR pathogens.

Age

  • HAP is more commonly reported in patients > 65 years, probably due to the fact that this age population is more commonly hospitalized.

Gender

  • There is no predominance in gender, although some data reports a higher incidence among females.

Ventilator-associated Pneumonia

  • VAP occurs in up to 25% of all people who require mechanical ventilation.
  • VAP can develop at any time during ventilation, but occurs more often in the first few days after intubation.
  • This is because the intubation process itself contributes to the development of VAP.
  • VAP occurring early after intubation typically involves fewer resistant organisms and is thus associated with a more favorable outcome.
  • Because respiratory failure requiring mechanical ventilation is itself associated with a high mortality, determination of the exact contribution of VAP to mortality has been difficult.
  • As of 2006, estimates range from 33% to 50% death in patients who develop VAP.
  • Mortality is more likely when VAP is associated with certain microorganisms (Pseudomonas, Acinetobacter), blood stream infections, and ineffective initial antibiotics.
  • VAP is especially common in people who have acute respiratory distress syndrome (ARDS).


References

  1. "CDC GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003" (PDF).
  2. Magill, Shelley S.; Edwards, Jonathan R.; Bamberg, Wendy; Beldavs, Zintars G.; Dumyati, Ghinwa; Kainer, Marion A.; Lynfield, Ruth; Maloney, Meghan; McAllister-Hollod, Laura; Nadle, Joelle; Ray, Susan M.; Thompson, Deborah L.; Wilson, Lucy E.; Fridkin, Scott K. (2014). "Multistate Point-Prevalence Survey of Health Care–Associated Infections". New England Journal of Medicine. 370 (13): 1198–1208. doi:10.1056/NEJMoa1306801. ISSN 0028-4793.
  3. "Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia". American Journal of Respiratory and Critical Care Medicine. 171 (4): 388–416. 2005. doi:10.1164/rccm.200405-644ST. ISSN 1073-449X.
  4. Eckenrode, Sheila; Bakullari, Anila; Metersky, Mark L.; Wang, Yun; Pandolfi, Michelle M.; Galusha, Deron; Jaser, Lisa; Eldridge, Noel (2014). "The Association between Age, Sex, and Hospital-Acquired Infection Rates: Results from the 2009–2011 National Medicare Patient Safety Monitoring System". Infection Control and Hospital Epidemiology. 35 (S3): S3–S9. doi:10.1086/677831. ISSN 0899-823X.

Template:WH Template:WS